Efficacy and safety of human papillomavirus vaccine for primary prevention of cervical cancer: A review of evidence from phase III trials and national programs

The Human Papillomavirus (HPV) vaccines have been widely introduced in the national immunization programs in most of the medium and high income countries following endorsement from national and international advisory bodies. HPV vaccine is unique and its introduction is challenging in many ways – it...

Descripción completa

Detalles Bibliográficos
Autores principales: Basu, Partha, Banerjee, Dipanwita, Singh, Priyanka, Bhattacharya, Chandrani, Biswas, Jaydip
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2013
Materias:
THE GREAT DEBATE: For HPV vaccine in cervical cancer
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3889021/
https://www.ncbi.nlm.nih.gov/pubmed/24455618
http://dx.doi.org/10.4103/2278-330X.119877

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3889021/
https://www.ncbi.nlm.nih.gov/pubmed/24455618
http://dx.doi.org/10.4103/2278-330X.119877

Ejemplares similares